Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Clinical Trials | Drug Development | Trials & Filings
Octapharma Extends Funding for COVID-19 Study
Study evaluating using IVIG as investigational coronavirus treatment for adults experiencing respiratory failure.Contract Pharma Staff 06.03.20
-
Clinical Trials | Drug Development | Industry News | Trials & Filings
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.Contract Pharma Staff 06.03.20
-
Analytical Services | Breaking News | CRO News | Drug Development | Industry News | Preclinical Outsourcing
Frontage Establishes Center of Excellence
Quantitative whole-body autoradiography CoE will be located in Exton, PA and headed by Michael Potchobia.Contract Pharma Staff 06.02.20
-
Breaking News | Collaborations & Alliances | Drug Development
Junshi Biosciences, Merck Partner on SCCHN Combo Therapy
To study anti-PD-1 mAb toripalimab (TUOYI) in combination with Cetuximab (Erbitux) in metastatic squamous cell carcinomas of the head and neck in China.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
Regeneron, Intellia Expand CRISPR/Cas9 Alliance
Provides Regeneron with rights to develop additional CRISPR/Cas9-based therapeutic targets and to jointly develop potential products for hemophilia A and B.Contract Pharma Staff 06.01.20
-
Breaking News | Drug Development | Industry News
Lilly's CYRAMZA Gains Sixth FDA Approval
CYRAMZA plus erlotinib is the first FDA-approved anti-VEGFR/EGFR TKI combination therapy for metastatic EGFR-mutated NSCLC.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
AbbVie, Jacobio Pharma Enter Strategic Pact
To develop and commercialize SHP2 inhibitors targeting a key node in cancer and immune cells.Contract Pharma Staff 06.01.20
-
Drug Development | Industry News | QA/QC
USP Provides Guidelines for rFC Reagent
Recombinant Factor C critical to development of vaccines and other sterile pharmaceutical products.Contract Pharma Staff 06.01.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
Daiichi Sankyo, Syneos Health Form Strategic ADC Alliance
Syneos to provide strategic and operational services for three lead Daiichi antibody drug conjugates.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Gilead and Arcus Ink $2B Cancer Partnership
To co-develop and co-commercialize next-generation cancer immunotherapiesContract Pharma Staff 05.29.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax
AAVCOVID, being developed by U.S. researchers in Massachusetts, leverages adeno-associated viral vector technology to produce immunity.Contract Pharma Staff 05.28.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Roche Initiates Phase III Trial in COVID-19 Pneumonia
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.Contract Pharma Staff 05.28.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Drug Development | Process Development
Arranta Bio Expands Microbiome Capacity at CoE
Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.Contract Pharma Staff 05.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
Novasep, Lysogene Enter Gene Therapy Collaboration
For development and production of GM1 gangliosidosis gene therapy productContract Pharma Staff 05.27.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
The Importance of CAR-T Cell Therapy in Clinical Trials
The Industry’s Evolving, Maturing FocusPanteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Glenmark Begins Phase III Trial of Anti-Viral Combo in COVID-19
To test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment.Contract Pharma Staff 05.26.20
-
Breaking News | Drug Development | Industry News
Accure Therapeutics Launches with €7.6M Series A Round
Alta Life Sciences and CDTI invest in new company that will develop portfolio of new medicines to address CNS diseasesContract Pharma Staff 05.26.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Chi-Med, BeiGene Enter Clinical Collaboration
Will evaluate combinations of surufatinib and fruquintinib with tislelizumab for multiple solid tumor cancer indicationsContract Pharma Staff 05.26.20
-
Biologics, Proteins, Vaccines | Drug Development | Promotions & Moves
Selexis Makes Scientific and Operational Promotions
Myriam Adam named ops and IP VP; Séverine Fagète named cell line development services VP; and Valérie Le Fourn, research VPContract Pharma Staff 05.19.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
